iptacopan 200 MG Oral Capsule
- RxCUI
- 2671074
- RxNorm name
- iptacopan 200 MG Oral Capsule
- Display name
- iptacopan 200 MG Oral Capsule
- Full name
- iptacopan 200 MG Oral Capsule
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:13
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FABHALTA | IPTACOPAN | Novartis Pharmaceuticals Corporation | a76b5845-6e21-4d3b-ad07-cd8df1b60bee | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | 2671074 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a76b5845-6e21-4d3b-ad07-cd8df1b60bee | iptacopan 200 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use FABHALTA safely and effectively. See full prescribing information for FABHALTA. FABHALTA ® (iptacopan) capsules, for oral use Initial U.S. Approval: 2023 | 20250320 |
| a76b5845-6e21-4d3b-ad07-cd8df1b60bee | iptacopan 200 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use FABHALTA safely and effectively. See full prescribing information for FABHALTA. FABHALTA ® (iptacopan) capsules, for oral use Initial U.S. Approval: 2023 | 20250320 |
| a76b5845-6e21-4d3b-ad07-cd8df1b60bee | iptacopan 200 MG (as iptacopan hydrochloride 225.8 MG) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use FABHALTA safely and effectively. See full prescribing information for FABHALTA. FABHALTA ® (iptacopan) capsules, for oral use Initial U.S. Approval: 2023 | 20250320 |